Mkts

Sarepta Therapeutics, Inc.

NASDAQ: SRPT
$16.42-0.82 (-4.76%)
As of Nov 10, 4:00 PM ET

Key statistics

Day range
16.1417.60
52-week range
14.6824.68
Today
Open17.59
Previous close16.42
Volume—
Valuation
Market cap1.85B
P/E ratio125.25×
EPS (TTM)-0.30
Income & risk
Dividend / yield—
Beta0.43
Avg volume2.87M
Discussion

SRPT News

Stories mentioning SRPT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue330,515442,934370,043513,123611,523658,412429,771360,548
Cost of Goods Sold
Gross Profit(29,101)219,268360,565473,959505,853338,080316,003
Operating Expenses
Research & Development
Sales General & Admin108,951128,29791,893137,897133,629163,873128,200138,796
Total Operating Expenses
Operating Income (Loss)358,433(411,583)(103,389)115,577(300,386)161,68122,196(701.00)
Interest Income6,3608,0707,2495,25410,1907,8827,5848,076
Interest Expense(21,713)(40,765)1,9005,228(4,503)(23,975)4,9184,832
Other Expense(15,259)(22,188)47,95338,061(83,132)10,06211,81014,278
Pretax Income343,174(278,296)(194,049)153,638(383,518)171,74334,00613,577
Tax Provision12,2154,551(14,102)(43,254)63,99012,694395.007,117
Net Income (Loss)330,959(412,226)(50,568)196,892(447,508)159,04933,6116,460
Earnings Per Share (Basic)3.15(3.93)(0.50)2.01(4.60)1.650.350.07
Earnings Per Share (Diluted)2.88(3.93)(0.50)1.89(4.60)1.500.340.07
Weighted Average Shares Outstanding (Basic)104,988100,120100,23798,00597,36295,07595,39094,618
Weighted Average Shares Outstanding (Diluted)121,916100,120100,237106,62397,362107,875100,44899,144

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About SRPT

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a stock listed on the Nasdaq Stock Market under the ticker symbol SRPT. It last traded at $16.42 (Nov 10, 2026, 4:00 PM ET), down 4.8% on the day. That gives Sarepta Therapeutics a market capitalisation of $1.8B and a price-to-earnings ratio of 125.3.

Over the past 52 weeks SRPT has traded between $14.68 and $24.68.

Revenue for the quarter ended Mar 31, 2026 was $330.5M; net income $331.0M. Revenue was down 46.0% from $611.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$330.5M$331.0M100.1%
Dec 31, 2025$442.9M-$412.2M-93.1%
Sep 30, 2025$370.0M-$50.6M-13.7%
Jun 30, 2025$513.1M$196.9M38.4%

From Sarepta Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…